Aims & Scope

Clin Exp Vaccine Res, the official English journal of the Korean Vaccine Society, is an international, peer reviewed, and open-access journal.

It covers all areas related to vaccines and vaccination.

Clin Exp Vaccine Res publishes editorials, review articles, special articles, original articles, case reports, brief communications, and correspondences covering a wide range of clinical and experimental subjects including vaccines and vaccination for human and animals against infectious diseases caused by viruses, bacteria, parasites and tumor.

The scope of the journal is to disseminate information that may contribute to elaborate vaccine development and vaccination strategies targeting infectious diseases and tumors in human and animals.

Relevant topics range from experimental approaches to (pre)clinical trials for the vaccine research based on, but not limited to, basic laboratory, translational, and (pre)clinical investigations, epidemiology of infectious diseases and progression of all aspects in the health related issues.

It is published printed and open accessed online issues (https://ecevr.org) two times per year in 31 January and 31 July.

Clin Exp Vaccine Res is linked to many international databases and is made freely available to institutions and individuals worldwide

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 1.3
2024 2.10

Journal Rank

Year Value
2024 14931

Journal Citation Indicator

Year Value
2024 154

SJR (SCImago Journal Rank)

Year Value
2024 0.358

Quartile

Year Value
2024 Q3

h-index

Year Value
2024 21

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.


APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
1.3
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.358
First Published: 2024

Quartile

Current Quartile
Q3
First Published: 2024

Similar Journals

Top Journals in Related Fields